Giving you medicine and more support
The GlaxoSmithKline Tykerb® CARES support program helps patients and the healthcare providers who treat them. All patients who are prescribed TYKERB are eligible for the Tykerb® CARES program.
As you start your treatment with TYKERB, Tykerb® CARES can help you by:
- Arranging to have your prescription for TYKERB filled through a specialty pharmacy
Your prescription will be shipped directly to your home unless you receive TYKERB directly from your doctor or treatment center. - Researching your insurance coverage
If you need help paying for your TYKERB, Tykerb® CARES will provide assistance with researching insurance coverage, including benefits verification, determining the lowest copay available, and alternative coverage options. - Calling you, if you choose, before you start treatment
A Tykerb® CARES consultant can review with you the information found in your Tykerb® CARES Starter Kit.
For more information about the Tykerb® CARES Program, contact your doctor or nurse.
The following specialty pharmacies distribute TYKERB:- Accredo Health Group, Inc.
- Advanced Care Scripts
- Aetna
- Biologics, Inc.
- Bioscrip®
- Cigna
- Commcare Pharmacy
- CVS-Caremark
- – Pharmacare
- – Caremark
- – CarePlus
- CuraScript
- Diplomat
- ICORE
- OncologyRx Care Advantage (US Oncology)
- Precision Rx
- SpecialtyScripts
- US Bioservices
- Walgreens Specialty Pharmacy
- – IVPCare
- – Medmark
- – OptionCare
The list of specialty pharmacies distributing TYKERB is subject to change without notice, so please continue to check this site for the most complete and up-to-date list.
Ask the Experts
Get answers to your questions about TYKERB.
Get More Information
Get updates from www.TYKERB.com.
Get support from Tykerb® CARES
Indication
TYKERB is indicated in combination with Xeloda® (capecitabine) for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and Herceptin® (trastuzumab).
Important Safety Information
Some women may develop liver damage while taking TYKERB. The cause of this damage is not known. In some cases, liver damage may be severe and may cause death. Your doctor should test your liver before and during treatment with TYKERB to check for signs of liver damage. You should contact your doctor if you have itching, yellow eyes or skin, dark urine, pain in your right upper side of your belly or feel very tired. If you develop liver damage during your treatment, your doctor may tell you to stop taking TYKERB. Before taking TYKERB, tell your doctor if you have liver problems. You may need a lower dose of TYKERB.
Before taking TYKERB, tell your doctor if you have heart problems. As with other treatments for HER2-positive advanced or metastatic breast cancer, there have been reports of changes in how the heart pumps blood through the body and how the heart beats. Call your doctor right away if you are short of breath, have rapid heartbeats (palpitations), or feel very tired.
Some people taking TYKERB have reported diarrhea. In some cases, diarrhea can be severe. Call your doctor right away if you have diarrhea. It is important to manage diarrhea with medicine as soon as it begins. Severe diarrhea may need to be treated with electrolytes and fluids given by mouth or by vein. Treatment with TYKERB may have to be delayed for a while or stopped completely.
If you have a dry cough or have shortness of breath, talk with your doctor. These may be signs of inflammation in the lungs.
Women should not become pregnant when taking TYKERB because the unborn baby may be harmed.
The most common side effects reported by patients taking TYKERB and Xeloda were diarrhea; vomiting; feeling sick to your stomach (nausea); feeling tired; red, painful hands and feet; and rash.
Tell your doctor about all the medicines you take, including prescription and nonprescription medicines and herbal and dietary supplements.
Because TYKERB is currently indicated to be taken with another medicine called Xeloda, be sure to talk with your doctor about any medicines and supplements that should be avoided when taking Xeloda.
Please see complete US Prescribing Information for TYKERB.
Xeloda is a registered trademark of Roche Laboratories Inc.
Herceptin is a registered trademark of Genentech, Inc.
Photos are for illustrative purposes only.
This website is funded and developed by GlaxoSmithKline.
This site is intended for US residents only.
© 1997-2010 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Contact Us